Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Published:2017-11 Issue:5 Volume:67 Page:918-924
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Berg Thomas,Simon Karl-Georg,Mauss Stefan,Schott Eckart,Heyne Renate,Klass Dietmar M.,Eisenbach Christoph,Welzel Tania Mara,Zachoval Reinhart,Felten Gisela,Schulze-zur-Wiesch Julian,Cornberg Markus,Op den Brouw Marjoleine L.,Jump Belinda,Reiser Hans,Gallo Lothar,Warger Tobias,Petersen Jörg

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Hepatology

Reference23 articles.

1. EASL Clinical Practice Guidelines: management of hepatitis B virus infection;J Hepatol,2017

2. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update;Liaw;Hepatol Int,2012

3. Chronic hepatitis B;Lok;Hepatology,2007

4. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

5. Safety of long-term nucleos(t)ide treatment in chronic hepatitis B;Ridruejo;Expert Opin Drug Saf,2012

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B;Antiviral Research;2024-09

2. JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2;Journal of Hepatology;2024-09

3. Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg‐negative hepatitis B virus‐related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis;Cancer Medicine;2024-08

4. Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment;Journal of Microbiology, Immunology and Infection;2024-08

5. Clinical trial: An open‐label, randomised trial of different re‐start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2024-07-05